ARV Stock-outs: More People Miss Doses In Chipinge

CHIPINGE recorded the highest number of households with members who missed Antiretroviral Treatment (ART) doses since beginning of the year 2019 at the back of drug stock outs amongst a host of other factors. By Michael Gwarisa Medicines stock-outs as for the period under review stood at 28% and was reported as the major reason for people missing ART doses while failure to access  health facilities  was at 20.9%, inadequate transport money to travel to health facilities 10.4% and forgetting to take medication by  members living with HIV 10.4%. According…

Share
Read More

Pepfar partners Hpsl in HIV- AIDS campaign

THE United States President’s Emergency Plan for AIDS Relief (PEPFAR) and the Harare Professionals Soccer League (Hpsl) joined hands this week to launch the PEPFAR- Hpsl Test and Score Football Tournament. During the tournament, Pepfar partners will work with male professionals on HIV prevention, HIV testing and adherence to treatment. At PEPFAR, we are excited about this partnership and we will be monitoring progress as you play soccer and get to know more about smart decisions to protect yourself from acquiring HIV,” said Dr Ponesai Nyika, Public Health Specialist at…

Share
Read More

Paediatric HIV A Neglected Disease

THERE are currently 1.8 million children living with HIV in Sub Saharan Africa, while 180 000 new HIV infections are recorded among children every year.  52% of these children were receiving antiretroviral therapy in 2017. By Michael Gwarisa In Zimbabwe however the number of children on ARVs has declined owing to a decline in mother to child transmission of HIV according to data released by the National Aids Council (NAC) and UNAIDS which indicates that the number of children on ART decreased from 89% in 2017 to 65% in 2018.…

Share
Read More

PrEP Use High Among Young African Girls But Fades After Three Months- Study

IN a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months. However, PrEP use fell among participants in this critical population during a year of follow-up clinic visits, although HIV incidence at 12 months was low. The preliminary results suggest that tailored, evidence-based adherence support strategies may be needed to durably engage young African women in consistent PrEP use. The study, known as HPTN…

Share
Read More

Close Service Gaps To End HIV/AIDS Among Children and Adolescents: UNAIDS

A new report released by UNAIDS today at the 10th IAS Conference on HIV Science in Mexico City, Mexico, shows that the world is lagging behind in its commitment to end the AIDS epidemic among children and adolescents. By Kudakwashe Pembere According to the report titled Start Free, Stay Free, AIDS Free the pace of progress in reducing new HIV infections among children and expanding access to treatment for children, adolescents and pregnant women living with HIV has slowed significantly. Further, global targets set for 2018 have been missed, despite…

Share
Read More

Parliament Petitioned Over ARV Shortages

PEOPLE Living With HIV (PLHIV) have handed over a petition to the Parliament of Zimbabwe in a bid to push government to urgently allocate financial resources to arrest the prevailing drug shortage before the situation goes out of hand. By Michael Gwarisa The development comes at the back of indications that the National Aids Council (NAC) is sitting on a cash pile of RTGS$20 million which they are failing to convert to United States (US) dollars needed to procure drugs from source markets. In an interview on the side-lines of…

Share
Read More

Is NAC On Autopilot?

IT’S been three months since Health and Child Care Minister, Dr Obadiah Moyo dismissed the whole National Aids Council (NAC) board over its failure to turn around fortunes of the organisation. By Michael Gwarisa Not only is NAC running without a board but the organisation has no substantive Chief Executive Officer (CEO) in place. Currently, Mr Raymond Yekeye the Operations Director has been CEO on an acting capacity  for the past six months now. As a news publication, we have made countless efforts to contact the Minster regarding the NAC…

Share
Read More

Lois Chingandu Joins Frontline AIDS

RENOWNED HIV and sexual reproductive health rights expert, Lois Chingandu has joined Frontline AIDS, a leading HIV and AIDS response organisation as its new Director of Evidence and Influence . By Michael Gwarisa Lois joins Frontline AIDS at a pivotal time for the organisation after serving at the helm of SAFAIDS Zimbabwe as Executive Director. The organisation, Frontline rebranded in February 2019 and is set to launch a new Global Plan of Action later this year and Lois together with her new team will play a central role in generating…

Share
Read More

Zim Annual TB Incidence Falls By 8%

CASES of new Tuberculosis (TB) infections have declined by 8% at the back of improved access to TB screening treatment and care at community level. By Michael Gwarisa The incidence of tuberculosis (TB) is defined as the number of new TB cases in one year per 100,000 population whereas  prevalence of tuberculosis is defined as the number of TB cases in a population at a given point in time (sometimes referred to as “point prevalence”) per 100,000 population Speaking at the Mid Term Review of the Zimbabwe National TB program,…

Share
Read More

Study for a child-friendly HIV treatment begins in Uganda

THE first patients have been enrolled in a potentially ground-breaking trial in Uganda for a capsule of granules containing four HIV drugs that can be easily administered to young children. Known as the ‘4-in-1,’ this sweet-tasting ‘fixed-dose combination’ could constitute a quantum leap in care for kids living with HIV, replacing a generation of sub-optimal HIV treatments that are difficult to give to children, or no longer recommended by the World Health Organization (WHO). The phase I/II study, called LOLIPOP, will provide clinical data on the 4-in-1 in infants and…

Share
Read More